CCR2/CCR5 inhibitor permits the radiation-induced effector T cell infiltration in pancreatic adenocarcinoma is a research paper published in The Journal of Experimental Medicine (2022). On theSindex it has a DataRank of 0. It has been cited 65 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01 CA169702
National Institutes of Health
Grant: R01 CA197296
National Institutes of Health
Grant: P01 CA247886
National Institutes of Health
Grant: T32 CA 9071-36
National Cancer Institute
Grant: P50 CA062924
Sidney Kimmel Comprehensive Cancer Center
Grant: P30 CA006973
NCI NIH HHS
Grant: T32 CA009071
National Institutes of Health
Grant: 3P30CA006973-53S2
Regional Oncology Research Center
National Institutes of Health
Grant: 5T32CA009071-08
ONCOLOGY: CHEMOTHERAPY, IMMUNOLOGY, BIOLOGY
National Institutes of Health
Grant: 5R01CA197296-05
Reprogramming the pancreatic tumor microenvironment with immunotherapy
National Institutes of Health
Grant: 5R01CA169702-05
Annexin A2 as a mediator of pancreatic cancer metastases
National Institutes of Health
Grant: 1P01CA247886-01A1
Transforming Human Pancreatic Cancer Into An Immunologic Disease
National Institutes of Health
Grant: 5P50CA062924-25
SPORE in Gastrointestinal Cancers
Bristol-Myers Squibb
American Society of Clinical Oncology
iTeos
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals